Loading…
A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 601 other SRES bills in the 113th — cohort avg 9d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2013 · fourth_quarter · Health Issues
S.RES.97 : A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs. S. 959, Pharmaceutical Compounding Quality and Accountability Act S. 957, Drug Supply Chain Security Act H.R.3204 Drug Quality and Security Act
Client expense: Not reported · Firm income: $50,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Pharmacy
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, And Generic Drugs, Pharmaceutical Drug CompoundingH.R. 486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R. 1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R. 2186 - VALID Compounding Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H. Res. - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S. 504 - Fair and Immediate Release of Generic Drugs Act S. 621 - Safe Prescribing Act of 2013 S. 957 - Drug Supply Chain Security Act S. 959 - Pharmaceutical Compounding S. Res. 97 - A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs
Client expense: $524,888 · Firm income: Not reported
Government targets: Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE, U.S. Trade Representative (USTR)
2013 · second_quarter · Health Issues
S. 959, Pharmaceutical Compounding Quality and Accountability Act S. 957, Drug Supply Chain Security Act S.RES.97 : A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs
Client expense: Not reported · Firm income: $51,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE